Posted by Larry Hoover on December 29, 2005, at 9:17:26
In reply to Re: Effexor metabolite submitted for FDA approval, posted by TrishP on December 29, 2005, at 6:57:32
> Ok - I'm still not sure. Does this mean maybe they can make an off shoot of Effexor that won't have such an awful discontinuation syndrome?
It's pretty likely to have about the same discontinuation syndrome. It hits the same receptors, in almost an identical manner. It has a slightly longer half-life, but not enough to really make a difference.
I think it's just a way to extend patent protection, in any way they can feasibly do so.
Lar
poster:Larry Hoover
thread:591573
URL: http://www.dr-bob.org/babble/20051221/msgs/593081.html